Literature DB >> 29574564

In vitro prediction of drug-induced cholestatic liver injury: a challenge for the toxicologist.

Mathieu Vinken1.   

Abstract

Entities:  

Keywords:  Adverse outcome pathway; Cholestasis; In vitro toxicology

Mesh：

Year:  2018        PMID： 29574564      PMCID： PMC6084771          DOI： 10.1007/s00204-018-2201-4

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN： 0340-5761            Impact factor:   5.153


× No keyword cloud information.
  61 in total

Review 1.  Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment.

Authors:  Gerald T Ankley; Richard S Bennett; Russell J Erickson; Dale J Hoff; Michael W Hornung; Rodney D Johnson; David R Mount; John W Nichols; Christine L Russom; Patricia K Schmieder; Jose A Serrrano; Joseph E Tietge; Daniel L Villeneuve
Journal:  Environ Toxicol Chem       Date:  2010-03       Impact factor: 3.742

2.  It's all about bile.

Authors:  James L Boyer
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

Review 3.  The adverse outcome pathway concept: a pragmatic tool in toxicology.

Authors:  Mathieu Vinken
Journal:  Toxicology       Date:  2013-08-23       Impact factor: 4.221

Review 4.  The role of Kupffer cells in hepatic diseases.

Authors:  Peizhi Li; Kun He; Jinzheng Li; Zuojin Liu; Jianping Gong
Journal:  Mol Immunol       Date:  2017-03-15       Impact factor: 4.407

5.  Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro.

Authors:  Wim F P M Van den Hof; Ainhoa Ruiz-Aracama; Anke Van Summeren; Danyel G J Jennen; Stan Gaj; Maarten L J Coonen; Karen Brauers; Will K W H Wodzig; Joost H M van Delft; Jos C S Kleinjans
Journal:  Toxicol In Vitro       Date:  2015-01-03       Impact factor: 3.500

6.  Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis.

Authors:  Benjamin L Woolbright; Kenneth Dorko; Daniel J Antoine; Joanna I Clarke; Parviz Gholami; Feng Li; Sean C Kumer; Timothy M Schmitt; Jameson Forster; Fang Fan; Rosalind E Jenkins; B Kevin Park; Bruno Hagenbuch; Mojtaba Olyaee; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2015-01-28       Impact factor: 4.219

7.  Integrative "-Omics" Analysis in Primary Human Hepatocytes Unravels Persistent Mechanisms of Cyclosporine A-Induced Cholestasis.

Authors:  Jarno E J Wolters; Marcel H M van Herwijnen; Daniel H J Theunissen; Danyel G J Jennen; Wim F P M Van den Hof; Theo M C M de Kok; Frank G Schaap; Simone G J van Breda; Jos C S Kleinjans
Journal:  Chem Res Toxicol       Date:  2016-12-02       Impact factor: 3.739

8.  Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells.

Authors:  Arefeh Ghodsizadeh; Adeleh Taei; Mehdi Totonchi; Ali Seifinejad; Hamid Gourabi; Behshad Pournasr; Nasser Aghdami; Reza Malekzadeh; Navid Almadani; Ghasem Hosseini Salekdeh; Hossein Baharvand
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

Review 9.  The potential of cytokines as safety biomarkers for drug-induced liver injury.

Authors:  Hugh G Laverty; Daniel J Antoine; Craig Benson; Masautso Chaponda; Dominic Williams; B Kevin Park
Journal:  Eur J Clin Pharmacol       Date:  2010-08-06       Impact factor: 2.953

Review 10.  Drug-induced cholestasis.

Authors:  Kalyan Ram Bhamidimarri; Eugene Schiff
Journal:  Clin Liver Dis       Date:  2013-11       Impact factor: 6.126
View more
  5 in total

1.  Industrial, Biocide, and Cosmetic Chemical Inducers of Cholestasis.

Authors:  Vânia Vilas-Boas; Eva Gijbels; Axelle Cooreman; Raf Van Campenhout; Emma Gustafson; Kaat Leroy; Mathieu Vinken
Journal:  Chem Res Toxicol       Date:  2019-06-18       Impact factor: 3.739

2.  Differential toxic effects of bile acid mixtures in isolated mitochondria and physiologically relevant HepaRG cells.

Authors:  Sophie L Penman; Parveen Sharma; Hélène Aerts; B Kevin Park; Richard J Weaver; Amy E Chadwick
Journal:  Toxicol In Vitro       Date:  2019-07-06       Impact factor: 3.500

3.  Protective effects of catalpol on mitochondria of hepatocytes in cholestatic liver injury.

Authors:  Xingjuan Gao; Jiaju Xu; Hongbo Liu
Journal:  Mol Med Rep       Date:  2020-07-13       Impact factor: 2.952

4.  Population pharmacokinetic model to generate mechanistic insights in bile acid homeostasis and drug-induced cholestasis.

Authors:  Véronique M P de Bruijn; Ivonne M C M Rietjens; Hans Bouwmeester
Journal:  Arch Toxicol       Date:  2022-07-25       Impact factor: 6.168

5.  Proteomic profiling of murine biliary-derived hepatic organoids and their capacity for drug disposition, bioactivation and detoxification.

Authors:  Lawrence Howell; Rosalind E Jenkins; Stephen Lynch; Carrie Duckworth; B Kevin Park; Christopher Goldring
Journal:  Arch Toxicol       Date:  2021-05-29       Impact factor: 5.153
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.